SHSE:688076 (China)
Â
Class A
Â¥
53.31
(-0.07%)
Nov 28
Business Description
Sinopep Allsino Bio Pharmaceutical Co Ltd
ISIN : CNE1000051X5
Share Class Description:
SHSE:688076: Class ACompare
Compare
Traded in other countries / regions
688076.China IPO Date
2021-05-19Description
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.5 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | 2.83 | |||||
| Interest Coverage | 18.68 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5 | |||||
| Beneish M-Score | -1.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.9 | |||||
| 3-Year EBITDA Growth Rate | 2 | |||||
| 3-Year EPS without NRI Growth Rate | -2.4 | |||||
| 3-Year Book Growth Rate | 19.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 62.79 | |||||
| Future 3-5Y Total Revenue Growth Rate | 45.78 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.36 | |||||
| 9-Day RSI | 47.47 | |||||
| 14-Day RSI | 47.04 | |||||
| 6-1 Month Momentum % | -4.88 | |||||
| 12-1 Month Momentum % | 24.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 298.49 | |||||
| Days Sales Outstanding | 91.57 | |||||
| Days Payable | 188.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.92 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 0.92 | |||||
| 5-Year Yield-on-Cost % | 0.91 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -4.85 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.73 | |||||
| Operating Margin % | 33.32 | |||||
| Net Margin % | 26.74 | |||||
| FCF Margin % | -31.37 | |||||
| ROE % | 18.48 | |||||
| ROA % | 11.31 | |||||
| ROIC % | 16.9 | |||||
| ROC (Joel Greenblatt) % | 24.3 | |||||
| ROCE % | 18.08 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.06 | |||||
| Forward PE Ratio | 20.4 | |||||
| PE Ratio without NRI | 25.51 | |||||
| Shiller PE Ratio | 183.83 | |||||
| Price-to-Owner-Earnings | 191.03 | |||||
| PEG Ratio | 1.1 | |||||
| PS Ratio | 7.48 | |||||
| PB Ratio | 4.48 | |||||
| Price-to-Tangible-Book | 5.13 | |||||
| Price-to-Operating-Cash-Flow | 31 | |||||
| EV-to-EBIT | 26.14 | |||||
| EV-to-EBITDA | 26.14 | |||||
| EV-to-Revenue | 7.82 | |||||
| EV-to-FCF | -25.46 | |||||
| Price-to-Graham-Number | 2.43 | |||||
| Price-to-Net-Current-Asset-Value | 2681.5 | |||||
| Earnings Yield (Greenblatt) % | 3.83 | |||||
| FCF Yield % | -4.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinopep Allsino Bio Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,576.335 | ||
| EPS (TTM) (Â¥) | 1.9 | ||
| Beta | 1.13 | ||
| Volatility % | 68.4 | ||
| 14-Day RSI | 47.04 | ||
| 14-Day ATR (Â¥) | 2.859314 | ||
| 20-Day SMA (Â¥) | 53.3175 | ||
| 12-1 Month Momentum % | 24.06 | ||
| 52-Week Range (Â¥) | 35.63 - 81.5 | ||
| Shares Outstanding (Mil) | 219.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinopep Allsino Bio Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinopep Allsino Bio Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinopep Allsino Bio Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076)'s stock price today?
The current price of SHSE:688076 is ¥53.31. The 52 week high of SHSE:688076 is ¥81.50 and 52 week low is ¥35.63.
When is next earnings date of Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076)?
The next earnings date of Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076) is .
Does Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076) pay dividends? If so, how much?
The Dividend Yield %  of Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076) is 0.92% (As of Today), Highest Dividend Payout Ratio of Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076) was 0.39. The lowest was 0.24. And the median was 0.32. The  Forward Dividend Yield % of Sinopep Allsino Bio Pharmaceutical Co Ltd(SHSE:688076) is 0.92%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers